OSAKA, Japan, May 31, 2021 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that Shionogi will implement the following corporate reorganization and personnel reassignment as of July 1, 2021.
1. Corporate Reorganization (see attached organization chart)
(1) New establishment of the DX Promotion Division
The DX Promotion Division will be newly established to assume the role of creating healthcare solutions using digital technology, making use of data to support the realization of the solutions, and building IT and security infrastructure. The Digital Intelligence Department of the Corporate Strategy Division will be incorporated into the DX Promotion Division. In addition, the related functions of the Corporate Planning Department of the Corporate Strategy Division and the Data Science Office of the Integrated Disease Care Division will be reorganized into the IT & Digital Solution Department and the Data Science Department under the DX Promotion Division.
(2) Reorganization of the Pharmaceutical Research Division
The Biomarker R&D Department, which has been an independent organization, will be incorporated into the Pharmaceutical Research Division to further strengthen the collaboration between research on disease prevention and treatment and research on diagnosis and biomarkers.
(3) Reorganization of the Pharmaceutical Commercial Division
Under the reorganization of the functions of the Sales Planning Department, the Sales Planning Office, which is responsible for improving, reforming, and supervising the operations of the entire Pharmaceutical Commercial Division, and the Sales Promotion Office, which is responsible for planning and promoting sales activities, including promoting disease strategies through activities for core hospitals centered on university hospitals, will be newly established.
(4) Reorganization of the Integrated Disease Care Division
The Disease Care Strategy Department will be incorporated and integrated into the New Product Planning Department to make the commercial strategy globally consistent from the research phase to the post-marketing phase, thereby further enhancing the comprehensive strategy planning function related to healthcare services. The Disease Care Strategy Office will be established under the New Product Planning Department to take on the planning function for each disease area in Japan.
(5) Reorganization of the Global Business Division
The Global Supply Chain Strategy Department of the Corporate Strategy Division will be under the Global Business Division to strengthen the business collaboration between global business and procurement and supply strategy planning functions.
(6) Reorganization of the Corporate Strategy Division
The Business Development Department of the Global Business Division will be incorporated into the Corporate Strategy Division to more strategically promote collaborative creation with various partners, which is the core activity in our Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)”.
(7) Reorganization of the Administration Division
The Sustainability Management Office of the Corporate Planning Department, Corporate Strategy Division, will be incorporated as the Sustainability Management Department under the Administration Division to promote fair corporate activities and further enhance governance and compliance functions while deepening collaboration with organizations in each Division. Meanwhile, to make the independence of the internal audit function clearer, the Internal Control Department will be directly under the President, independent of all Divisions.
2.Personnel Reassignments (Effective; July 1, 2021)
New (or continuing) Position |
Name |
Present Position |
DX Promotion Division |
||
Corporate Officer, Senior Vice President, DX Promotion Division and IT & Digital Solution Department |
Takeshi Shiota |
Corporate Officer, Senior Vice President, Corporate Planning Department |
Vice President, Data Science Department |
Yoshitake Kitanishi |
Senior Director, Data Science Office |
Pharmaceutical Research Division |
||
Senior Vice President, Pharmaceutical Research Division and Laboratory for Drug Discovery and Development |
Jun Yoshimoto |
Senior Vice President, Global Development Division and Clinical Research Department |
Vice President, Research Planning Department |
Shouko Kan-o |
Project Management Department |
Vice President, Laboratory for Drug Discovery and Disease Research |
Gaku Sakaguchi |
Vice President, Biomarker R&D Department |
Vice President, Laboratory for Advanced Medicine Research |
Takashi Mizukawa |
Vice President, Research Planning Department |
Vice President, Biomarker R&D Department |
Tomoyuki Yukizawa |
President, Shionogi Pharmacovigilance Center Co., Ltd. |
Drug Development and Regulatory Science Division |
||
Vice President, Clinical Research Department |
Takeki Uehara |
Drug Development and Regulatory Science Division |
Vice President, Pharmacovigilance Department |
Masako Kaneto |
Vice President, Laboratory for Drug Discovery and Development |
CMC R&D Division |
||
Senior Director, CMC Planning Office |
Takeshi Sakai |
CMC Planning Office |
Vice President, API R&D Laboratory |
Akira Ino |
Vice President, Laboratory for Advanced Medicine Research |
Vice President, Formulation R&D Laboratory |
Minoru Hasegawa |
Vice President, Laboratory for Drug Discovery and Disease Research |
Vice President, Analytical R&D Laboratory |
Yasunori Aoyama |
Vice President, API R&D Laboratory |
Pharmaceutical Commercial Division |
||
Senior Director, Sales Planning Office |
Wataru Imamura |
Sales Planning Department |
Senior Director, Sales Promotion Office |
Masanori Kuroiwa |
Sales Planning Department |
Senior Director, Specialty Product Office |
Toshiyuki Aoi |
Senior Director, Pharmaceutical Promotion Department - Region 5 |
Senior Director, Pharmaceutical Promotion Department - Region 2 |
Atsushi Nakamura |
Sales Planning Department |
Senior Director, Pharmaceutical Promotion Department - Region 4 |
Masashi Katsumata |
President, Shionogi Marketing Solutions Co., Ltd. |
Senior Director, Pharmaceutical Promotion Department - Region 5 |
Kazuya Ishida |
Pharmaceutical Promotion Department - Region 6 |
Senior Director, Pharmaceutical Promotion Department - Region 6 |
Masao Morishita |
Senior Director, Specialty Product Office |
Senior Director, Pharmaceutical Promotion Department - Region 7 |
Souichirou Mitsutake |
Sales Planning Department |
Senior Director, Disease Care Strategy Office |
Yohji Urago |
Disease Care Strategy Department |
Vice President, Corporate Social Responsibility Department and Office for Children’s Bright Future |
Hiroyuki Tanaka |
Vice President, Corporate Social Responsibility Department |
Senior Director, Drug Information Center |
Takashi Fukunaga |
Medical Affairs Department |
Corporate Quality Assurance Supervisor |
||
Vice President, Quality Assurance Department |
Kumiko Numa |
Vice President, Analytical R&D Laboratory |
Global Business Division |
||
Senior Executive Officer, Global Business Division |
Kohji Hanasaki |
Senior Executive Officer, Corporate Strategy Division |
Corporate Strategy Division |
||
Senior Executive Officer, Corporate Strategy Division |
John Keller |
Senior Executive Officer, Global Business Division |
Vice President, Corporate Planning Department |
Susumu Mitsumori |
Vice President, Disease Care Strategy Department |
Administration Division |
||
Senior Executive Officer, Senior Vice President, Administration Division and Legal Affairs Department |
Noriyuki Kishida |
Senior Executive Officer, Senior Vice President, Administration Division |
Vice President, Sustainability Management Department |
Masako Kudou |
Senior Director, Sustainability Management Office |
Other |
||
Vice President, Internal Control Department |
Kenji Matsuo |
President, Shionogi Business Partner Co., Ltd. |
Japanese group companies |
||
President, Shionogi Pharmacovigilance Center Co., Ltd. |
Yuka Niimi |
Pharmacovigilance Department |
President, Shionogi Marketing Solutions Co., Ltd. |
Minoru Mitsuda |
Vice President, Commercial Division and Sales Planning Department |
President, Shionogi Business Partner Co., Ltd. |
Shigeki Fujita |
Finance & Accounting Department |